CompletedPhase 1NCT01938729

Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma

Studying Cholangiocarcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Memorial Sloan Kettering Cancer Center
Principal Investigator
Andrea Cercek, MD, M.D
Memorial Sloan Kettering Cancer Center
Intervention
Liver resection and placement of hepatic artery infusion pump(procedure)
Enrollment
8 enrolled
Eligibility
18 years · All sexes
Timeline
2013 – 2020

Study locations (5)

Collaborators

Ohio State University · University of Texas Southwestern Medical Center · Washington University School of Medicine

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01938729 on ClinicalTrials.gov

Other trials for Cholangiocarcinoma

Additional recruiting or active studies for the same condition.

See all trials for Cholangiocarcinoma →

← Back to all trials